About 50% of the miRNAs that were upregulated in metastatic PCa MLL have a binding site in the 3′-UTR of CP110, which suggests that simultaneously with miR-129-3p other miRNAs may also contribute to the control of CP110 levels and centrosome function. The gene discussed is KMT2A; the disease is posterior cortical atrophy.